Bluestem Oral Care has added an educational component to its brand with a series of blogs, videos, and webinars focussing on topics related to companion pet oral health concerns and strategies. The video series is called “In-depth Insights into Pet Oral Care” and features discussions from Chief Veterinary Officer Dr. Jean Gauvin DVM and Chief Scientific Officer Dr. Gordon Guay Ph.D., from parent company Kane Biotech. Both Dr. Gauvin and Dr. Guay bring a wealth of knowledge and experience in antimicrobial stewardship to pet health and product development.
Dr. Gauvin opens up about how “the video series will be instrumental in helping people better understand why oral care is important for their pet and, more importantly, will provide them with the tools they need to deliver against this. We invite listeners to send us all their pet oral care questions through our Facebook page @bluestempets, and we’ll do our best to answer as many as we can through our Q&A series.”
Dr. Guay comments on his “excitement to leverage some of the work that I’ve done previously for big multinational companies to help pet owners keep their pets’ oral health in great condition, through the development of a number of products that are both effective and safe for everyday use. I believe people are going to do the right thing for their pets if they understand what’s critical for their health and their well-being.”
About Dr. Jean Gauvin
Dr. Gauvin has forty years of experience in veterinary medicine and is the co-founder and co-owner of the DMV Veterinary Centre in Montreal (Lachine), Quebec. He is the Chairman of the Canadian Veterinary Medical Association’s (CVMA) communications advisory group; the former President of the Association des Médecins Vétérinaire du Québec en pratique des petits animaux (AMVQ) and past Chairman and member of the AMVQ’s governance committee. Dr. Gauvin received his Doctorate in Veterinary Medicine and Small Animal Dentistry Certificate from the University of Montreal, and his Certificate in Fish Health Management from the University of Georgia.
Dr. Gauvin joined Kane Biotech for the opportunity to pursue his three passions: animal welfare, antimicrobial stewardship, and the World Organization for Animal Health’s concept of ‘One Health.’ Dr. Gauvin has stated that he is “completely supportive of Kane Biotech’s vision of discovering new technologies that will prevent biofilm-related infections in humans and animals, as well as in industrial settings.”
About Dr. Gordon Guay
Dr. Guay has over twenty-five years of experience in R&D and new product development. He has worked as a Research Fellow at Proctor and Gamble, serving as the lead scientist within a range of different P&G business units, including Oral-B, Gillette, Olay, Right Guard, CoverGirl, Max Factor and Duracell. Dr. Guay has received over 11 international awards for new products developed during his tenure at P&G. Before P&G, Gordon was the Director of Research at Catalytic Antibodies Inc. Dr. Guay received a Ph.D. in molecular genetics from the University of Illinois. His research focused on bacterial resistance to sulfonamides. He also conducted post-Doctoral work at Lederle Laboratories on the substrate specificity of tetracycline efflux pumps.
Dr. Guay commented, “Kane Biotech is uniquely positioned to become the industry leader in solving biofilm resistance challenges facing people, pets, and industries. I’m proud to drive the development of improved antimicrobial technologies and products as Chief Scientific Officer.”